Boomi CEO Steve Lucas’ New Book ‘ Digital Impact’ Becomes a National Bestseller, Topping USA Today and Publishers Weekly Lists
Boomi™, the intelligent integration and automation leader, today announced that Chairman and CEO Steve Lucas is now a national bestselling author with the release of his new book, Digital Impact: The Human Element of AI-Driven Transformation (Wiley). Since its debut, the book has rapidly climbed national bestseller charts — including multiple appearances on USA TODAY’s Bestselling Books lists, and Publishers Weekly Bestseller List. Digital Impact resonates deeply with business leaders navigating the intersection of AI and human-centered innovation, offering a timely blueprint for more thoughtful, effective digital transformation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429280721/en/
Boomi CEO Steve Lucas’ New Book ‘Digital Impact’ Becomes a National Bestseller, Topping USA Today and Publishers Weekly Lists
With AI continuing to dominate executive agendas, Digital Impact offers a fresh perspective — one that emphasizes empathy, trust, and responsibility alongside innovation and speed. Lucas draws on decades of leadership experience to deliver an actionable roadmap for organizations looking to unlock the value of AI while staying grounded in human values.
“Becoming a national bestseller is an incredible honor, but more importantly, it shows how urgent and universal this conversation has become,” Lucas said. “AI is transforming business at an unprecedented pace. Digital Impact is a call to action for leaders to ensure that transformation is guided by purpose, ethics, and a focus on people.”
Following its recent debut, Digital Impact has achieved remarkable early momentum across national bestseller lists, including:
- #11 on USA TODAY’s Bestselling Book List (Overall)
Digital Impact made a stunning debut, ranking #11 across all categories on USA TODAY’s national Bestselling Book List — an incredible achievement that reflects the book’s broad appeal beyond just the business and tech world.
- #5 on USA TODAY’s Bestselling List for Nonfiction
Among all nonfiction titles, Digital Impact entered the charts at #5, positioned alongside some of the most influential thought leadership and current affairs titles in the country.
- #3 on USA TODAY’s Bestselling List for Business Books
The book secured the #3 spot among business books, underscoring its relevance for today’s leaders looking to understand and navigate AI-driven transformation with a human-first mindset.
- #18 on Publishers Weekly Hardcover Nonfiction Bestseller List
In its first week of eligibility, Digital Impact also made its debut at #18 on Publishers Weekly’s Hardcover Nonfiction Bestseller List, a trusted benchmark for the publishing industry that reflects strong sales performance and national traction.
Early praise for the book highlights its relevance in today’s AI-driven world, with executives, CIOs, and tech influencers citing Digital Impact as a must-read for anyone navigating digital change.
The book is now available at major retailers, including Amazon, Barnes & Noble, and Books-A-Million.
To learn more, visit: boomi.com/digitalimpact
About Boomi
Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.
© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429280721/en/
Contacts
Media Contacts:
Kristen Walker | (415) 613-8320 | kristenwalker@boomi.com
David Wolpert | (972) 743-8477 | david@fortierpr.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aptiv and Vecna Robotics to Develop Next Generation Autonomous Mobile Robots18.12.2025 14:00:00 CET | Press Release
Aptiv PLC (NYSE: APTV), a global industrial technology leader, and Vecna Robotics, a pioneer in AI-driven autonomous material handling solutions, today announced a strategic collaboration to co-develop next-generation Autonomous Mobile Robot (AMR) solutions designed to deliver cost-efficient automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218958100/en/ Aptiv’s advanced perception portfolio and machine learning technologies will be integrated into Vecna Robotics’ platform. This partnership combines Aptiv’s industry-leading portfolio, with Vecna Robotics’ advanced autonomy and orchestration platform to provide safer, more efficient, and scalable material handling systems. “Automation is transforming the way goods move through warehouses and factories, with devices that sense, think and act in real time,” said Javed Khan, Executive Vice President, Intelligent Systems, Aptiv. “Our collaboration with Vecna Robotics
Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions18.12.2025 14:00:00 CET | Press Release
Syremis Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health, today announced its launch with a $165 million financing. The Series A, co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, GV (Google Ventures), QVT, and Pictet will support the advancement of Syremis’ pipeline through clinical proof of concept. Schizophrenia and other psychotic disorders remain among the most debilitating and underserved conditions worldwide, with more than 20 million people affected and facing considerable disability, elevated relapse rates, and reduced life expectancy. Despite decades of need, current treatments often fall short in both efficacy and tolerability. Syremis’ lead program, ST-905, is a dual M1/M4 muscarinic agonist under development for schizophrenia and other neuropsychiatric conditions and is currently in Phase 1. The molecule’s differentiated potency
Cinemo at CES 2026: Hyper-Personalized Experiences in the Car and Beyond18.12.2025 13:55:00 CET | Press Release
Cinemo, a global leader and highly innovative one-stop-shop provider for fully integrated digital media products is presenting its newest innovations in exclusive live demos at CES 2026 in Las Vegas, from January 6-9. Cinemo will present a range of in-car experiences that bring intelligence, hyper-personalization, and entertainment to every moment - elevating every ride into a unique experience for drivers and passengers. From collaborative trip planning to effortless onboarding, every feature is crafted to enable fascinating experiences with the right content at the right time for the right audience - for the perfect ride. Passengers can enjoy personalized media recommendations, immersive gaming, and a consistent, intuitive experience across every seat, screen, and journey. This will mark Cinemo’s first time presenting these demo showcases live of breakthrough solutions that redefine the future of in-vehicle intelligence. Cinemo is bringing agentic AI into the vehicle and is extending
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press Release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom